Alligator Bioscience
0,83 SEK +13,23%3 investorer følger denne virksomhed
Alligator Bioscience is a research-based biotechnology company that uses patented technology to develop biological drug candidates in inflammation and cancer. The company is active in the former part of the drug development chain. Alligator Bioscience has a global technology platform and is active in a rapidly growing segment of the pharmaceutical market - protein drugs. The company was founded in 2001 and is headquartered in Lund, Sweden.
Omsætning
58,11 mio.
EBIT %
-428,46 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
ATORX
Daglig lav / høj pris
0,71 / 0,87
SEK
Markedsværdi
629,96 mio. SEK
Aktieomsætning
3,5 mio. SEK
Volumen
4,5 mio.
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
Allegro Investment | 32,9 % | 33,0 % |
Roxette Photo | 8,6 % | 8,6 % |
Avanza Pension | 2,8 % | 2,8 % |
Magnus Petersson | 2,8 % | 2,8 % |
Nordnet Pension Insurance | 2,4 % | 2,4 % |
Johan Zetterstedt | 2,2 % | 2,2 % |
Handelsbanken Funds | 1,8 % | 1,8 % |
Lars Spånberg | 1,3 % | 1,3 % |
Zetterstedt Holding AB | 0,7 % | 0,7 % |
Harri Salminen | 0,7 % | 0,7 % |
ViserAlle indholdstyper
Redeye: Alligator Bioscience Q3 2024 - Approaching the Decisive Moment
Alligator Bioscience AB reports financial results for the first 9 months of 2024 and for Q3 2024 and provides a business update
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools